Ipratropium Bromide

Question 1

Inpratopium Mechanism of action

Answer 1

A. Promotes interaction of acetylcholine at receptor sites of bronchial smooth muscle, resulting in decreased cynic guanosine monophosphate and brobchodilation

Question 2

Ipratropium adverse reactions / side effects: Headache, dizziness, nervousness, fatigue, tremor, blurred vision, cough dyspnea, worsening COPD, symptoms, tachycardia, palpitations, flushing, MI, dry mouth, nausea, vomiting, GI Distress

True or False

Answer 2

True

Question 3

Special considerations: When used in combination with beta - agonist ( eg, metaproternol and albuterol), the beta agonist is always administered first with a 5 minute wait before administering ipratropium. Shake well before use. Use with caution in patients with urinary retention

True or false

Answer 3

True

Question 4

Duration of action:

Answer 4

Onset: 1 - 3 minutes

Peak effect: 90 to 120 minutes

duration: 4 to 6 hours

Question 5

Ipratopium indications

A. persistent bronchospasm, COPD exacerbation

B. ESRD, Asthma, CHF

C. CHF, COPD

Answer 5

A. persistent bronchospasm, COPD exacerbation

Question 6

Ipratropium class

Answer 6

Anticholinergic, bronchodilator

Question 7

Pregnancy class

Answer 7

B

Question 8

Adult dose

Answer 8

250 to 500 mcg via inhalation with handheld nebulizer every 20 minutes up to 3 minutes

Question 9

Ipratropim has several drugs that is known to have negative interactions with, specially in the pediatric population

true or false

Answer 9

false

Question 10

contraindications?

Answer 10

Hypersensitivity to ipratopium, atopine, alkaloids, peanuts